Altshuler David's Form 4 filing
Vertex Pharmaceuticals Inc (VRTX) · filed Feb 16, 2023
- Accession no.
- 0001209191-23-010045
- Filed
- Feb 16, 2023
- Trade date
- Feb 14, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 6 non-derivative transactions. Open-market sales total $1.91M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Altshuler DavidCIK 0001550395 | Officer (EVP, Global Research and CSO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 14, 2023 | Common Stock | SSaleDisposed | −800 | $295.79F2,F3 | −$236,632 | 53,596 | Direct | |
| Feb 14, 2023 | Common Stock | SSaleDisposed | −842 | $296.85F2,F4 | −$249,947.7 | 52,754 | Direct | |
| Feb 14, 2023 | Common Stock | SSaleDisposed | −395 | $297.97F2,F5 | −$117,698.15 | 52,359 | Direct | |
| Feb 14, 2023 | Common Stock | SSaleDisposed | −2,165 | $299.08F2,F6 | −$647,508.2 | 50,194 | Direct | |
| Feb 14, 2023 | Common Stock | SSaleDisposed | −1,888 | $300.11F2,F7 | −$566,607.68 | 48,306 | Direct | |
| Feb 14, 2023 | Common Stock | SSaleDisposed | −308 | $301.02F2,F8 | −$92,714.16 | 47,998 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Dr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Referenced by the price of 6 transactions in Table I.
- F3
Open market sales reported on this line occurred at a weighted average price of $295.79 (range $295.31 to $296.12).
Referenced by the price of 1 transaction in Table I.
- F4
Open market sales reported on this line occurred at a weighted average price of $296.85 (range $296.42 to $297.37).
Referenced by the price of 1 transaction in Table I.
- F5
Open market sales reported on this line occurred at a weighted average price of $297.97 (range $297.50 to $298.35).
Referenced by the price of 1 transaction in Table I.
- F6
Open market sales reported on this line occurred at a weighted average price of $299.08 (range $298.71 to $299.54).
Referenced by the price of 1 transaction in Table I.
- F7
Open market sales reported on this line occurred at a weighted average price of $300.11 (range $299.76 to $300.70).
Referenced by the price of 1 transaction in Table I.
- F8
Open market sales reported on this line occurred at a weighted average price of $301.02 (range $300.79 to $301.22).
Referenced by the price of 1 transaction in Table I.